Switching statins
- 8 June 2006
- Vol. 332 (7554) , 1344-1345
- https://doi.org/10.1136/bmj.332.7554.1344
Abstract
Footnotes Competing interests RB has received lecture honorariums from AstraZeneca, Aventis, and Pfizer for speaking at educational meetings. References w1-w4 are on bmj.comKeywords
This publication has 5 references indexed in Scilit:
- Atorvastatin in Patients with Type 2 Diabetes Mellitus Undergoing HemodialysisNew England Journal of Medicine, 2005
- Comparison of the efficacy and safety of rosuvastatin versus atorvastatin, simvastatin, and pravastatin across doses (STELLAR * Trial)Published by Elsevier ,2003
- A 52-week, multicenter, randomized, parallel-group, double-blind, double-dummy study to assess the efficacy of atorvastatin and simvastatin in reaching low-density lipoprotein cholesterol and triglyceride targets: the treat-to-target (3T) study.2003
- ACC/AHA/NHLBI clinical advisory on the use and safety of statinsJournal of the American College of Cardiology, 2002
- Comparative Dose Efficacy Study of Atorvastatin Versus Simvastatin, Pravastatin, Lovastatin, and Fluvastatin in Patients With Hypercholesterolemia (The CURVES Study) fn1fn1This study was supported by Parke-Davis, Division of Warner Lambert Company, Morris Plains, New Jersey. Manuscript received August 20, 1997; revised manuscript received and accepted November 24, 1997.The American Journal of Cardiology, 1998